Sutro Biopharma (STRO) EBIT (QoQ) (2017 - 2025)
Sutro Biopharma (STRO) EBIT (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Sutro Biopharma | 202.59 Mn | 61.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.48% |
| Sep 30, 2025 | -1,348.70% |
| Jun 30, 2025 | 95.12% |
| Mar 31, 2025 | -4.99% |
| Dec 31, 2024 | 3.92% |
| Sep 30, 2024 | -39.51% |
| Jun 30, 2024 | 13.97% |
| Mar 31, 2024 | -231.14% |
| Dec 31, 2023 | 198.04% |
| Sep 30, 2023 | 4.69% |
| Jun 30, 2023 | -9.33% |
| Mar 31, 2023 | 14.19% |
| Dec 31, 2022 | -132.07% |
| Sep 30, 2022 | -9.45% |
| Jun 30, 2022 | 50.48% |
| Mar 31, 2022 | -11.69% |
| Dec 31, 2021 | -1.04% |
| Sep 30, 2021 | -253.64% |
| Jun 30, 2021 | 48.42% |
| Mar 31, 2021 | 23.48% |